Navigation Links
Chinese Medicinal Compound Stops Formation of Cysts in Polycystic Kidney

Using a compound from a centuries-old Chinese traditional medicine, Yale University researcher Dr. Craig Crews has been able to prevent the formation of kidney-destroying// cysts in a mouse model of polycystic kidney disease. This ability holds out hope for what would be the first treatment, other than kidney transplant or frequent dialysis, for one of the most lethal of all kidney diseases worldwide.

Triptolide is derived from a Chinese medicinal herb, named Lei Gong Teng, which has been used in traditional medicine to treat cancer, inflammation, and auto-immune diseases and, more recently, also has been tested in Phase I clinical trials as an anti-tumor agent.

This study, with mice bred to have a disease like human polycystic kidney disease, used triptolide with a less toxic concentration than that used in cancer chemotherapy trials. At that level, the compound marked reduced cyst formation in the mice compared to genetically similar mice not taking the compound.

During normal kidney development, cells lining the kidney tubules continue growing and dividing until they receive a signal that the tubule is fully formed. The switch that turns on that signal consists of the growth regulatory proteins PKD1 and PKD2, located on hair-like cilia in the lining of the developing tubules. When urine begins flowing through the tubules, the flow bends the cilia that sets off the signal that no more growth is needed.

In people who have a mutation in one of these growth regulatory proteins, however, the message to stop growing never gets delivered, even when urine is flowing and the cilia are bending. It is as if the phone is ringing but the cell can't hear it. So, never sensing a signal to stop, the cells lining the fully-formed kidney tubules keep right on subdividing and growing. The result of this hyperproliferative, unregulated growth: uncontrolled growth of cells lining the tubules and the formation of large cysts in the kidn eys.

The vast majority - 85 percent - of patients with polycystic kidney disease have a gene causing PKD1 to be missing or to function poorly. Because most patients inherit only one abnormal gene and one functional gene, the body is usually able to compensate for the faulty gene and the person retains kidney function during the 20s and 30s. But through random mutagenesis, the remaining good copy of PKD1 is lost in some cells, which then switch to the hyperproliferative state. As the person's kidney begins to develop these cysts, the kidney begins to swell, and the person moves to either dialysis or transplant in order to survive.

That means a treatment that slows down the development of cysts does not have to stop their production completely to be effective, says Dr. Crews.

"If we were able to slow the rate of cyst formation by even 10 percent a year, compounded annually, patients would not die from this disease. A relatively small effect would have an enormous clinical benefit," says Dr. Crews.

Source-Eurekalert/V
'"/>




Related medicine news :

1. Chinese paracetamol may be slapped with dumping duty
2. Stay young the Chinese way
3. A Chinese herb kills cancer cells
4. Chinese herbal remedies aids in cancer treatment
5. Prohibited diet medicine found in Chinese herbs
6. Global Outbreak Of Bird Flu Warning By Chinese Scientist
7. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
8. Unscrupulous Chinese Medicine traders putting lives at risk
9. Chinese City Suspends Water Supply Fearing Pollution
10. Running Water Restored In Chinese City
11. Mass Bird flu vaccination to Chinese Poultry
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 10, 2016 , ... President Obama’s ... Advantage organizations to deliver medical services via telehealth, estimated to generate more than ... for such language for many years. Although there is more to be ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... as the World Molecular Imaging Congress (WMIC), will be held in New York ... meeting is “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... is known locally for a series of therapeutic sessions to help Los Angeles-area ... characters and in their lives. The series, known as “Mindfulness for Actors and ...
(Date:2/10/2016)... ... February 10, 2016 , ... Early this week, Team Iconic at ... of Nestlé KITKAT as the first global confectionery brand sourced from 100% sustainable cocoa. ... the quality of their product, through activities that focus on better farming, better lives ...
(Date:2/10/2016)... , ... February 10, 2016 , ... LaserShip, a regional ... to the Food Bank of Eastern Michigan last Friday in order to aid in ... into the Midwest to include a facility located in Clio, only 15 miles away ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 11, 2016 http://www.researchandmarkets.com/research/rp4pg8/molecular ... "Molecular Diagnostics Reports Bundle" report ... ) has announced the addition of the ... to their offering. --> Research ... the addition of the "Molecular Diagnostics ...
(Date:2/10/2016)... 11, 2016  QT Vascular Ltd., together with its ... with its subsidiaries, the "Group"), is pleased to ... AngioScore, Inc. ("ÄngioScore") (now owned by Spectranetics Corporation ... the United States Court of Appeals ... an earlier district court order (the "DCO").   The ...
(Date:2/10/2016)...  Fotona, based in the U.S. and Europe ... PRO Lightwalker dental laser at the upcoming 151 st ... 2016 in booth #4815. The ST PRO is a full ... the features of the award winning, industry leading Lightwalker ATS. At ... will be very attractive to many dentists hesitating to incorporate ...
Breaking Medicine Technology: